Hangzhou Zhongtai Cryogenic Technology Corporation
SZSE:300435.SZ
13.44 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 3,047.457 | 3,256.425 | 2,406.997 | 1,977.5 | 1,034.33 | 594.732 | 485.58 | 337.164 | 462.464 | 432.77 | 379.623 | 308.609 | 192.704 |
Cost of Revenue
| 2,461.68 | 2,699.583 | 1,951.187 | 1,565.506 | 804.645 | 443.502 | 355.038 | 229.437 | 300.298 | 270.331 | 245.926 | 192.277 | 115.373 |
Gross Profit
| 585.777 | 556.842 | 455.81 | 411.994 | 229.686 | 151.23 | 130.542 | 107.727 | 162.167 | 162.44 | 133.697 | 116.332 | 77.331 |
Gross Profit Ratio
| 0.192 | 0.171 | 0.189 | 0.208 | 0.222 | 0.254 | 0.269 | 0.32 | 0.351 | 0.375 | 0.352 | 0.377 | 0.401 |
Reseach & Development Expenses
| 64.126 | 59.817 | 40.383 | 19.198 | 25.594 | 23.504 | 15.657 | 15.337 | 14.177 | 12.952 | 11.506 | 9.099 | 6.995 |
General & Administrative Expenses
| 42.745 | 46.682 | 43.288 | 39.8 | 33.816 | 33.096 | 15.652 | 8.344 | 9.292 | 6.975 | 4.892 | 7.961 | 3.573 |
Selling & Marketing Expenses
| 39.719 | 41.218 | 40.081 | 31.736 | 22.534 | 11.939 | 10.245 | 11.881 | 8.493 | 9.822 | 7.459 | 7.25 | 5.004 |
SG&A
| 82.464 | 87.9 | 83.37 | 71.536 | 56.35 | 45.035 | 25.897 | 20.225 | 17.785 | 16.797 | 12.351 | 15.211 | 8.577 |
Other Expenses
| -0.271 | 53.335 | 41.93 | 46.752 | 29.491 | 3.474 | 21.676 | 1.108 | 10.843 | 3.589 | 0.559 | 2.589 | 0.233 |
Operating Expenses
| 207.075 | 201.052 | 165.682 | 137.487 | 111.435 | 93.686 | 63.188 | 57.973 | 54.614 | 50.306 | 43.899 | 40.414 | 25.761 |
Operating Income
| 431.629 | 344.992 | 305.857 | 268.57 | 138.123 | 68.572 | 49.118 | 65.371 | 97.318 | 90.302 | 76.965 | 60.115 | 42.211 |
Operating Income Ratio
| 0.142 | 0.106 | 0.127 | 0.136 | 0.134 | 0.115 | 0.101 | 0.194 | 0.21 | 0.209 | 0.203 | 0.195 | 0.219 |
Total Other Income Expenses Net
| -0.271 | 10.091 | 5.207 | 0.874 | -43.903 | 14.502 | 3.44 | 16.725 | 0.609 | -18.243 | -12.274 | -13.214 | -9.171 |
Income Before Tax
| 431.357 | 355.083 | 311.064 | 269.444 | 94.22 | 72.046 | 70.794 | 66.479 | 108.161 | 93.891 | 77.524 | 62.704 | 42.399 |
Income Before Tax Ratio
| 0.142 | 0.109 | 0.129 | 0.136 | 0.091 | 0.121 | 0.146 | 0.197 | 0.234 | 0.217 | 0.204 | 0.203 | 0.22 |
Income Tax Expense
| 82.13 | 78.071 | 65.537 | 76.176 | 16.813 | 7.525 | 10.577 | 9.61 | 15.788 | 13.958 | 11.371 | 9.841 | 6.025 |
Net Income
| 350.061 | 277.959 | 245.353 | 196.109 | 77.436 | 67.636 | 60.204 | 56.869 | 92.373 | 79.933 | 66.153 | 52.863 | 36.375 |
Net Income Ratio
| 0.115 | 0.085 | 0.102 | 0.099 | 0.075 | 0.114 | 0.124 | 0.169 | 0.2 | 0.185 | 0.174 | 0.171 | 0.189 |
EPS
| 0.92 | 0.73 | 0.65 | 0.52 | 0.29 | 0.28 | 0.25 | 0.24 | 1.23 | 0.44 | 0.37 | 0.29 | 0.2 |
EPS Diluted
| 0.91 | 0.73 | 0.65 | 0.52 | 0.29 | 0.27 | 0.25 | 0.23 | 1.23 | 0.44 | 0.37 | 0.29 | 0.2 |
EBITDA
| 534.222 | 500.543 | 410.798 | 351.791 | 161.448 | 97.609 | 102.502 | 71.701 | 135.34 | 128.428 | 100.653 | 88.966 | 60.321 |
EBITDA Ratio
| 0.175 | 0.154 | 0.171 | 0.178 | 0.156 | 0.164 | 0.211 | 0.213 | 0.293 | 0.297 | 0.265 | 0.288 | 0.313 |